Value | Category | Cases | |
---|---|---|---|
ACCEUILLE ET COMMUNICATION EN MILIEU DE SOIN SANTE | 1 |
1.1%
|
|
ALAITEMENT DES JEUNES ENFANTS | 1 |
1.1%
|
|
ALIMENTATION DU JEUNE ENFANT ET DU NOURRISSON | 1 |
1.1%
|
|
ALIMENTATION DU NOURISSON ET DU JEUNE ENFANT | 1 |
1.1%
|
|
ALIMENTATION DU NOURRISSON ET DU JEUNE ENFANT | 3 |
3.2%
|
|
ALLAITEMENT | 1 |
1.1%
|
|
ALLAITEMENT MATERNEL DU JEUNE ENFANT | 1 |
1.1%
|
|
AMUNION | 1 |
1.1%
|
|
ANJE | 1 |
1.1%
|
|
ASPIRATION MANUELLE INTRA UTERINE | 1 |
1.1%
|
|
ASSURANCE QUALITE DES SOINS | 1 |
1.1%
|
|
AUDIT | 1 |
1.1%
|
|
AUDITS DE DECES | 1 |
1.1%
|
|
CARDIAQUE | 1 |
1.1%
|
|
CPN(SENSIBILISATION) | 1 |
1.1%
|
|
DEPISTAGE DES LESIONS PRECANCEREUSES DU COL | 1 |
1.1%
|
|
DIARRHEE | 1 |
1.1%
|
|
ENCADREMENTS STAGIAIRES | 1 |
1.1%
|
|
ETUDE IMNINOLOGIQUE DU VACCIN MENA | 1 |
1.1%
|
|
EXCLUSIF EXCISSION | 1 |
1.1%
|
|
FEMININE | 1 |
1.1%
|
|
FORMATION CONTINUE DES INFIRMIERS CHEF DE POSTE | 1 |
1.1%
|
|
FORMATION CONTINUE DES SAGES FEMMES | 1 |
1.1%
|
|
FORMATION DES FORMATEURS | 1 |
1.1%
|
|
FORMATION DES SAGES FEMMES | 1 |
1.1%
|
|
GDT | 1 |
1.1%
|
|
GENRE ET DEVELOPPEMENT | 1 |
1.1%
|
|
GESTION DE LACTATION | 1 |
1.1%
|
|
GESTION DES CSPS ETUDE CAS TEMOIN MONITORING | 1 |
1.1%
|
|
GTD GUIDE DE DIAGNOSTIC ET DE TRAITEMENT | 1 |
1.1%
|
|
HYGIENE HOSPITALIERE | 1 |
1.1%
|
|
IFC | 1 |
1.1%
|
|
INFECTIONS RESPIRATION AIGUES | 1 |
1.1%
|
|
INTRODUCTION DES NOUVEAUX VACCINS | 1 |
1.1%
|
|
INTRODUCTION DU NOUVEAU VACCIN | 1 |
1.1%
|
|
IST VIH | 2 |
2.1%
|
|
L AGENT DECLARE N AVOIR PAS RECU DE FORMATION | 1 |
1.1%
|
|
L EXCISION | 1 |
1.1%
|
|
LACTATION | 2 |
2.1%
|
|
LE REC | 1 |
1.1%
|
|
LEPRE | 1 |
1.1%
|
|
LYMPHATIQUE | 1 |
1.1%
|
|
LYMPHOEDEME | 1 |
1.1%
|
|
MALADIES TROPICALES NEGLIGEES | 1 |
1.1%
|
|
MENINGITE | 2 |
2.1%
|
|
MGF | 1 |
1.1%
|
|
MGF AUDITE ET DECES MATERN | 1 |
1.1%
|
|
MOMI | 3 |
3.2%
|
|
MOMI PRIX EN CHARGE POUR LA CONSULTATION | 1 |
1.1%
|
|
MONITORING | 1 |
1.1%
|
|
MONITORING COMMUNAUTAIRE | 1 |
1.1%
|
|
MONITORING, PHARMACOVIGILANCE | 1 |
1.1%
|
|
NOMA SRO | 1 |
1.1%
|
|
NOUVEAUX VACCINS | 1 |
1.1%
|
|
ODI | 1 |
1.1%
|
|
OPHTAMOLOGIE | 1 |
1.1%
|
|
OPTIMISE | 1 |
1.1%
|
|
ORL OPHTALMOLOGIE | 1 |
1.1%
|
|
PARTHOGRAMME | 1 |
1.1%
|
|
PARTOGRAMME | 3 |
3.2%
|
|
PLAN D'ACTION DES CSPS | 1 |
1.1%
|
|
PLAN DE PREPARATION A L'ACCOUCHEMENT | 1 |
1.1%
|
|
PORT DU CONDOM | 1 |
1.1%
|
|
POST PARTUM | 1 |
1.1%
|
|
POST VACCINALES | 1 |
1.1%
|
|
PREPARATION A L ACCOUCHEMENT | 1 |
1.1%
|
|
PRISE EN CHARGE DE NOUVEAU NE VIA | 1 |
1.1%
|
|
PRISE EN CHARGE IST | 1 |
1.1%
|
|
REPARATION SEQUELLES EXCISION | 1 |
1.1%
|
|
SASDE | 1 |
1.1%
|
|
SOINS ESSENTIELS DU NOUVEAU NE | 1 |
1.1%
|
|
SOINS INFIRMIER | 1 |
1.1%
|
|
SOINS MATERNEL NEONATALE PARTOGRAMME ALLAITEMENT | 1 |
1.1%
|
|
SQUAC VIM | 1 |
1.1%
|
|
SRO ZINC | 5 |
5.3%
|
|
SRO-ZINC | 1 |
1.1%
|
|
SURVEILLANCE DES EFFETS SECONDAIRES DES MEDICAMENT | 1 |
1.1%
|
|
URGENCE MEDICO CHIRURGICALE | 1 |
1.1%
|
|
UTILISATION DU GDT ALAITEMENT MATERNEL EXCLUSIF | 1 |
1.1%
|
|
UTILISATION DU SRO ET DU ZINC | 1 |
1.1%
|
|
VIH PEDIATRIQUE BOUILLIE ENRICHIE | 1 |
1.1%
|
This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.